These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26212105)

  • 1. Targeting the CD80/CD86 costimulatory pathway with CTLA4-Ig directs microglia toward a repair phenotype and promotes axonal outgrowth.
    Louveau A; Nerrière-Daguin V; Vanhove B; Naveilhan P; Neunlist M; Nicot A; Boudin H
    Glia; 2015 Dec; 63(12):2298-312. PubMed ID: 26212105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
    Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of CD80 and CD86 with CD28 and CTLA4.
    Ellis JH; Burden MN; Vinogradov DV; Linge C; Crowe JS
    J Immunol; 1996 Apr; 156(8):2700-9. PubMed ID: 8609386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
    Mukherjee S; Ahmed A; Malu S; Nandi D
    J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution.
    Oshima S; Karrer EE; Paidhungat MM; Neighbors M; Chapin SJ; Fan RA; Reed MA; Wu K; Wong C; Chen Y; Whitlow M; Anderson FA; Bam RA; Zhang Q; Larsen BR; Viswanathan S; Devens BH; Bass SH; Higashi Y
    Protein Eng Des Sel; 2016 May; 29(5):159-67. PubMed ID: 26968452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S; Maiti PK; Nandi D
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity and cross-reactivity engineering of CTLA4-Ig to modulate T cell costimulation.
    Xu Z; Juan V; Ivanov A; Ma Z; Polakoff D; Powers DB; Dubridge RB; Wilson K; Akamatsu Y
    J Immunol; 2012 Nov; 189(9):4470-7. PubMed ID: 23018459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive effect of ASP2408, a novel CD86-selective variant of CTLA4-Ig, in rats and cynomolgus monkeys.
    Oshima S; Fujii Y; Karrer EE; Takamura F; Chapin SJ; Neighbors M; Viswanathan S; Devens BH; Higashi Y; Mizuhara H
    Int Immunopharmacol; 2016 Nov; 40():310-317. PubMed ID: 27662596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S; Ahmed A; Nandi D
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression.
    Cutolo M; Montagna P; Soldano S; Contini P; Paolino S; Pizzorni C; Seriolo B; Sulli A; Brizzolara R
    Clin Exp Rheumatol; 2015; 33(2):250-4. PubMed ID: 25896473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of costimulatory molecules in the bovine corpus luteum.
    Cannon MJ; Davis JS; Pate JL
    Reprod Biol Endocrinol; 2007 Jan; 5():5. PubMed ID: 17266770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice.
    Mathur M; Herrmann K; Qin Y; Gulmen F; Li X; Krimins R; Weinstock J; Elliott D; Bluestone JA; Padrid P
    Am J Respir Cell Mol Biol; 1999 Oct; 21(4):498-509. PubMed ID: 10502560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA4-Ig preserves thymus-derived T regulatory cells.
    Ahmadi SM; Hölzl MA; Mayer E; Wekerle T; Heitger A
    Transplantation; 2014 Dec; 98(11):1158-64. PubMed ID: 25269023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune suppression in cynomolgus monkeys by XPro9523: an improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn.
    Bernett MJ; Chu SY; Leung I; Moore GL; Lee SH; Pong E; Chen H; Phung S; Muchhal US; Horton HM; Lazar GA; Desjarlais JR; Szymkowski DE
    MAbs; 2013; 5(3):384-96. PubMed ID: 23549103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
    Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
    Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis.
    Israël-Assayag E; Fournier M; Cormier Y
    J Immunol; 1999 Dec; 163(12):6794-9. PubMed ID: 10586079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice.
    Barrios CS; Johnson BD; D Henderson J; Fink JN; Kelly KJ; Kurup VP
    Clin Exp Immunol; 2005 Nov; 142(2):242-50. PubMed ID: 16232210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
    Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M
    J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4.
    Horspool JH; Perrin PJ; Woodcock JB; Cox JH; King CL; June CH; Harlan DM; St Louis DC; Lee KP
    J Immunol; 1998 Mar; 160(6):2706-14. PubMed ID: 9510170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.